Nickenig, C <br/><br/>
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jan 2007 
 - 136-142 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdl348  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carmustine--therapeutic use<br/>Chlorambucil--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Cytarabine--therapeutic use<br/>Dexamethasone--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Etoposide--therapeutic use<br/>Female<br/>Germany--epidemiology<br/>Hematopoietic Stem Cell Mobilization<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Lymphoma, Follicular--drug therapy<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Male<br/>Melphalan--therapeutic use<br/>Middle Aged<br/>Mitoxantrone--therapeutic use<br/>Prednisolone--therapeutic use<br/>Prednisone--therapeutic use<br/>Prospective Studies<br/>Survival Rate<br/>Treatment Outcome<br/>Vincristine--therapeutic use